01:46 PM EST, 02/26/2025 (MT Newswires) -- Renovaro ( RENB ) said Wednesday it agreed to a merger with artificial intelligence-driven drug discovery company BioSymetrics.

Financial terms of the transaction were not disclosed.

The company said it expects to close the transaction in March, with the combined company integrating BioSymetrics' Elion platform into Renovaro's ( RENB ) workflow.

Shares of Renovaro ( RENB ) were up more than 35% in recent trading.

Price: 1.05, Change: +0.27, Percent Change: +35.19